Takara Bio Inc. (TYO:4974)
783.00
-7.00 (-0.89%)
Jun 13, 2025, 3:30 PM JST
Takara Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 29,549 | 35,416 | 51,847 | 23,633 | 25,993 | Upgrade
|
Cash & Short-Term Investments | 29,549 | 35,416 | 51,847 | 23,633 | 25,993 | Upgrade
|
Cash Growth | -16.57% | -31.69% | 119.38% | -9.08% | 28.26% | Upgrade
|
Receivables | 14,017 | 11,285 | 12,448 | 17,804 | 12,585 | Upgrade
|
Inventory | 12,439 | 11,850 | 11,087 | 24,065 | 9,183 | Upgrade
|
Other Current Assets | 1,674 | 4,208 | 2,187 | 2,639 | 1,354 | Upgrade
|
Total Current Assets | 57,679 | 62,759 | 77,569 | 68,141 | 49,115 | Upgrade
|
Property, Plant & Equipment | 56,954 | 49,075 | 40,956 | 36,395 | 29,766 | Upgrade
|
Long-Term Investments | 1,727 | 556 | 560 | 476 | 420 | Upgrade
|
Goodwill | 6,516 | 6,488 | 6,674 | 6,309 | 6,149 | Upgrade
|
Other Intangible Assets | 1,455 | 1,539 | 2,373 | 2,850 | 3,224 | Upgrade
|
Long-Term Deferred Tax Assets | 1,003 | 833 | 1,067 | 1,539 | 1,075 | Upgrade
|
Other Long-Term Assets | - | 2 | 3 | 2 | 1 | Upgrade
|
Total Assets | 125,334 | 121,252 | 129,202 | 115,712 | 89,750 | Upgrade
|
Accounts Payable | 1,652 | 1,543 | 2,323 | 1,959 | 2,077 | Upgrade
|
Accrued Expenses | 1,003 | 962 | 1,065 | 923 | 739 | Upgrade
|
Current Portion of Leases | 193 | 180 | 151 | 137 | 138 | Upgrade
|
Current Income Taxes Payable | 1,984 | 2,047 | 5,077 | 9,941 | 6,057 | Upgrade
|
Other Current Liabilities | 2,299 | 2,436 | 5,759 | 4,420 | 4,180 | Upgrade
|
Total Current Liabilities | 7,131 | 7,168 | 14,375 | 17,380 | 13,191 | Upgrade
|
Long-Term Leases | 908 | 788 | 821 | 910 | 1,003 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 179 | 198 | - | Upgrade
|
Other Long-Term Liabilities | 459 | 411 | 382 | 373 | 454 | Upgrade
|
Total Liabilities | 9,487 | 9,469 | 16,749 | 19,649 | 15,448 | Upgrade
|
Common Stock | 14,965 | 14,965 | 14,965 | 14,965 | 14,965 | Upgrade
|
Additional Paid-In Capital | 32,893 | 32,893 | 32,893 | 32,893 | 32,893 | Upgrade
|
Retained Earnings | 52,465 | 53,471 | 57,047 | 45,009 | 27,085 | Upgrade
|
Comprehensive Income & Other | 15,176 | 10,175 | 7,313 | 3,005 | -761 | Upgrade
|
Total Common Equity | 115,499 | 111,504 | 112,218 | 95,872 | 74,182 | Upgrade
|
Minority Interest | 348 | 279 | 235 | 191 | 120 | Upgrade
|
Shareholders' Equity | 115,847 | 111,783 | 112,453 | 96,063 | 74,302 | Upgrade
|
Total Liabilities & Equity | 125,334 | 121,252 | 129,202 | 115,712 | 89,750 | Upgrade
|
Total Debt | 1,101 | 968 | 972 | 1,047 | 1,141 | Upgrade
|
Net Cash (Debt) | 28,448 | 34,448 | 50,875 | 22,586 | 24,852 | Upgrade
|
Net Cash Growth | -17.42% | -32.29% | 125.25% | -9.12% | 29.80% | Upgrade
|
Net Cash Per Share | 236.25 | 286.08 | 422.50 | 187.57 | 206.39 | Upgrade
|
Filing Date Shares Outstanding | 120.42 | 120.42 | 120.42 | 120.42 | 120.42 | Upgrade
|
Total Common Shares Outstanding | 120.42 | 120.42 | 120.42 | 120.42 | 120.42 | Upgrade
|
Working Capital | 50,548 | 55,591 | 63,194 | 50,761 | 35,924 | Upgrade
|
Book Value Per Share | 959.17 | 925.99 | 931.92 | 796.18 | 616.05 | Upgrade
|
Tangible Book Value | 107,528 | 103,477 | 103,171 | 86,713 | 64,809 | Upgrade
|
Tangible Book Value Per Share | 892.97 | 859.33 | 856.79 | 720.11 | 538.21 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.